Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE study

OBJECTIVES: To evaluate the efficacy of denosumab for progressive bone erosion in risk factor subgroups of Japanese RA patients. METHODS: This study included 340 RA patients on MTX from the dose-response study of Denosumab in patients with RheumatoId arthritis on methotrexate to Validate inhibitory...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiguro, Naoki, Tanaka, Yoshiya, Yamanaka, Hisashi, Yoneda, Toshiyuki, Ohira, Takeshi, Okubo, Naoki, Genant, Harry K, van der Heijde, Désirée, Takeuchi, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532444/
https://www.ncbi.nlm.nih.gov/pubmed/30602032
http://dx.doi.org/10.1093/rheumatology/key416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532444/
https://www.ncbi.nlm.nih.gov/pubmed/30602032
http://dx.doi.org/10.1093/rheumatology/key416

Ejemplares similares